Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABSW) Asset Utilization Ratio (2021 - 2025)

SAB Biotherapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 105.01% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 105.01%, while the annual FY2024 figure was 0.02, 37.84% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per SABSW's latest filing, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.75 in Q1 2022 to a low of 0.0 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.24, with a median of 0.09 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 37.68% in 2022, then plummeted 105.01% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.61 in 2021, then fell by 24.79% to 0.46 in 2022, then tumbled by 91.37% to 0.04 in 2023, then crashed by 32.33% to 0.03 in 2024, then crashed by 105.01% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for SABSW's Asset Utilization Ratio are 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025).